A

Aelis Farma SA
PAR:AELIS

Watchlist Manager
Aelis Farma SA
PAR:AELIS
Watchlist
Price: 1.085 EUR -1.36% Market Closed
Market Cap: 14.9m EUR

Wall Street
Price Targets

AELIS Price Targets Summary
Aelis Farma SA

There are no price targets for AELIS.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Aelis Farma SA Competitors:
Price Targets
AMRN
Amarin Corporation PLC
11% Downside
688428
InnoCare Pharma Ltd
82% Upside
OXB
Oxford BioMedica PLC
24% Upside
IKT
Inhibikase Therapeutics Inc
246% Upside
2480
Beijing Luzhu Biotechnology Co Ltd
34% Upside
PYXS
Pyxis Oncology Inc
509% Upside
CRNX
Crinetics Pharmaceuticals Inc
68% Upside
300122
Chongqing Zhifei Biological Products Co Ltd
33% Upside

Revenue
Forecast

Revenue Estimate
Aelis Farma SA

The compound annual growth rate of Aelis Farma SA's revenue for the next 3 years is 162%.

N/A
Past Growth
162%
Estimated Growth
Estimates Accuracy
-41%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Aelis Farma SA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Aelis Farma SA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
73%
Average Beat
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is AELIS's stock price target?
Not Available

AELIS doesn't have any price targets made by Wall Street professionals.

What is Aelis Farma SA's Revenue forecast?
Projected CAGR
162%

The compound annual growth rate of Aelis Farma SA's revenue for the next 3 years is 162%.

Back to Top